@biorxivpreprint.bsky.social Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells www.biorxiv.org/content/10.1... Great work @maxkonigmd.bsky.social

Your Orwellian Government at work - National Cancer Institute Employees Can’t Publish Information on These Topics Without Special Approval #NIH www.propublica.org/article/nati...

The #RheumMadness podcast is back! Join us as we discuss the T'd Up T-Cells Region, including: -BiTEs with @maxkonigmd.bsky.social -CD40L inhibitor for #Sjogren's with Duke rheum -Abatacept for pre-RA with Allegheny rheum rheummadness.buzzsprout.com/1465681/epis...

Findings highlight ‘critical importance’ of infectious complications after CAR-T - read HemeOncToday interview with Kai Rejeski and me #medsky #CARTcells www.healio.com/news/hematol...

Targeting autoreactive TRBV9+ T cells using TRBV9xCD3 bispecific T cell engaging antibodies. Controlling ankylosing spondylitis and celiac disease without increasing the risk of infection? Let's go. Join us at Room 150, 3:00 PM. #precisionimmunotherapy #ACR24

#ACR24 with emerging pathology superstar Jin Liu. APS session done. More on BaiTEs to come.

While at it, if you are interested in learning more about off-the-shelf precision immunotherapies for the treatment of lupus, please join our talk on 9G4xCD3 T cell-engaging antibodies during the SLE - Cellular Therapy Session at 3 PM. #ACR24

Congrats to Jin Liu for being awarded the ACR Emerging Investigator Excellence Award for her work on 9G4-targeted CAR/cTCR-T cells for the treatment of lupus. Join her talk today in the SLE - Cellular Therapy Session at 3 PM. #ACR24 #ProundMentorMoment

Congrats to Steph Glavaris for being awarded the ACR Emerging Investigator Excellence Award for her work on T cell-engaging antibodies to deeply deplete TRBV9+, autoreactive T cells in ankylosing spondylitis and celiac disease. #ACR24 #ProundMentorMoment